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Abstract 
Hepatitis B and hepatitis C virus are two major public health problems in the country. The purpose of this study was to compare the 
prevalence of hepatitis B and hepatitis C in different areas of District Malakand. A total of 280 individuals were bled. Primary 
screenings were performed by using ICT SD Strip for anti HCV and anti-HBsAg. The final diagnosis of hepatitis was done using 
Enzyme linked immunosorbent assay (ELISA) kit. Anti HCV was found positive in 30 (10.71%), HBs Ag was positive in 27 (9.64%) 
and no record were found in individuals having both conditions. This study showed a similar prevalence of HCV and HBV infection 
in blood donors. The prevalence of hepatitis B and C virus can be minimized by the screening of all donors for anti -HCV and HBs 
Ag and discouraging the use of unsterilized syringes.   
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INTRODUCTION 
Hepatitis B virus (HBC) and Hepatitis C virus (HCV) 
are the dynamic and projecting source of morbidity and 
mortality worldwide especially in developing countries like 
Pakistan (Shah and Shabbir, 2002). Hepatitis B virus was 
first isolated and confirmed in 1963 and infected over 2 
billion people around the globe (Cusheri, 2002). This virus 
is vital source of cirrhosis, HCC, and hepatitis 
(Abdolsamadi, 2009), and was reported by World Health 
Organization (WHO) that almost 3% of all world population 
was infected by this minute agent (Fisman et al., 2002). 
Approximately 780,000 deaths were recorded by WHO 
among 240 million chronic HBV individuals (WHO, 2015). 
According to WHO reports, about 180 million people are 
infected by hepatitis C virus in world and 3-4 million people 
are infected every year. Prevalence rate of Hepatitis C 
(HCV) in Pakistan is from 4.5% to 8 % (about 10 million 
people), that is second highest in the world (Irfan et al., 
2016). First serological marker for hepatitis B virus was first 
revealed by Blumberg and colleagues in 1963 (Blumberg, 
1977) and that of hepatitis C virus were cloned in 1989 
(Choo et al., 1989; Kuo et al., 1989). About 6-8% patients 
of chronic condition of HCV develop HCC. Hepatitis B virus 
(HBV) and hepatitis C virus (HCV) are risk factor for 
Hepatocellular Carcinoma (HCC) and cirrhosis. Chronic 
infection of HCV leads to extra-hepatic disorders, 
hepatocellular carcinoma, renal disorders, hematologic 
diseases and cirrhosis (Ali et al., 2015). It is reported that 
elevation of liver enzymes responsible for liver disorders 
(Toor et al., 2016). These complications also develop in 
IFN-α cured patient. Number of studies also reported 
thyroid dysfunction after interferon treatments (Tomer et al., 
2007; Andrade et al., 2011). Lead acetate alters the serum 
AST and ALT levels by affecting the liver (Khanam et al., 
2016). Blood transfusions, unsterilized surgical instruments, 
outdoor barber shops, untrained medical instructors, 
unsafe sexual contacts and vertical transmission are 
regarded as the chief routs of transmission. Vertical 
transmission was reported the most prominent route of 
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transmission of hepatitis C viral infection Worldwide 
(Cottrell et al., 2013; Benova et al., 2014). The risk of 
vertical transmission was recorded at ˂0.1% in Pakistan 
(UNAIDS, 2016). 
Occurrence of hepatitis C virus infection has been 
increased in Pakistan showing 60 to 70 percent HCV 
positive cases (Jafri et al., 2006), and was recorded second 
after Egypt in HCV with total infection of 10 million people 
(Waheed, 2015). Genotype 3a and 2 are mostly reported in 
Pakistan (Umer and Iqbal, 2016; Khan et al., 2014).  
This study was directed to evaluate the prevalence of 
hepatitis B and C virus in general people of District 
Malakand, Khyber Pakhtunkhwa, and to investigate the 
common risk factors. 
  
MATERIALS AND METHODS 
Collection of blood samples 
Blood samples were collected from all the tested 
individuals by authorized technician, kept in heparanized 
tubes and transported to laboratory in the insulated ice 
boxes. Samples were centrifuged at 4000 rpm for 10 min to 
isolate the plasma and stored at -20°C. 
  
ICT for HBV and HCV 
The samples were screened primarily by using ICT 
devices to separate out the positive samples of hepatitis B 
and C virus. Three full drops were loaded under strict 
sterile condition in to screening device wells and reaction 
color was produced due to coated antigens. Two lines 
indicated positive results as shown in figure 1. Single line 
showed negative results. 
 
 
 
Fig. 1. ICT SD Strip Method 
 
Enzyme linked immunosorbent assay (ELISA) for 
hepatitis B  
ICT positive samples of HBV were further analyzed 
and confirmed by using HBsAg kit (Equipar, Italy) based on 
one-step “Sandwich” ELISA. This device uses two separate 
antibodies directed to two different epitopes. One absorbed 
onto walls of plate while another one labeled to horseradish 
peroxidase (HRP) enzymes. Both samples and conjugate 
were loaded at the same time to micro-plate and incubated 
at 37°C. Second incubation was done with chromogen 
which detects the specific immune-complex on the surface 
of solid phase. Enzyme generated color intensity was 
proportional to its antigen in isolated blood samples which 
was further analyzed by ELISA reader. 
  
Enzyme linked immunosorbent assay (ELISA) for 
hepatitis C  
The hepatitis C kit (Equipar, Italy) contained the micro 
plate that was coated with specific recombinant protein 
analogues of antigens of hepatitis C virus. The plate was 
first treated with liquid sample then with horseradish 
labeled monoclonal antibody anti-H-IgG, and further 
incubated to generate color.  Enzymatic activity that creates 
color indication was proportional to hepatitis C antibodies 
present in tested samples. The result was evaluated by 
ELISA reader. 
 
RESULTS AND DISCUSSION 
In this study, a total of 280 patients were screened for 
hepatitis B and C virus. Total of 144 (51.42%) samples 
were recorded as male patient and 136 (48.57%) were 
females of different age groups ranging from 13 to 85 years 
as shown in figure 2. All these patients belonged to rural 
areas of District Malakand. Total of 57 patients were found 
positive for both hepatitis B and C viruses. Out of these 
positive, 27 (9.64%) were recorded hepatitis B positive and 
30 (10.71%) for hepatitis C. Total occurrence of male HBV 
positive were recorded 14 (5.0%) and 13 (4.64%) were 
female patients. 17 (6.07%) were HCV positive male while 
13 (4.6%) were female patients. Both hepatitis B and C 
were found in 57 (20.35%) patients. Amongst them 31 
(11.07%) were male and 26 (9.28%) were females (Figure 
3). 
HBV and HCV achieved an endemic situation in many 
countries of the world, especially in underdeveloped 
countries. In Pakistan, it has been recorded an alarming 
threat especially in rural areas of country, as can be 
perceived from our results too. A large proportion of 
population is already affected with HBV and HCV with 
prevalence rate of 10% for HBV and 4-7% for HCV. While 
in rural areas the percentage has been recorded 
significantly higher, than quoted one
 
(Malik et al., 1999). 
 
 
Fig. 2. Sex wise distribution among 280 patients 
screened for hepatitis. 
Male 
51% 
Female 
49% 
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Fig. 3. Prevalence of Hepatitis in different areas of 
Malakand 
 
The major route of this transmission was found due to 
blood transfusion and the use of unsterilized syringes or 
instruments especially dental instruments, surgical and un-
screened blood transfusion (Todorova et al., 2015). Other 
factors involved in the spread of infection are persons who 
have their armpits or face shaved by street barber or those 
involved in sexual abuse
 
(Luby, 1997; Khwaja et al., 2002; 
Thornburn et al., 2003). HCV percentage prevalence in the 
adult population was 11.55%. HCV genotype 3a 
prevalence was found to be 63.45%, the highest of all 
genotypes. The percentage prevalence of HCV found for 
all of the provinces was Punjab: 5.46%, Sindh: 2.55%, 
Khyber Pakhtoonkhaw: 6.07%, Balochistan: 25.77%, and 
federally administrated tribal areas: 3.37% (Arshad and 
Ashfaq, 2017). Similarly the percentage of co-infection HBV 
with diabetes was reported to be 12.80% (Muhammad et 
al., 2013). In another study the prevalence of HBV was 
found in the 46-60 years age group for malarial patients. 
Among male patients, rate of infection was 25% while in 
females rate was 23% (Dilshad et al., 2016). 
 
CONCLUSION  
The study concluded that Hepatitis B virus (HBC) and 
Hepatitis C virus (HCV) are major cause of hepatitis and 
liver cirrhosis and achieved an alarming situation in 
Pakistan especially in those areas which lack education 
and awareness. The use of unsterilized surgical tools, 
unscreened blood transfusion procedure, unqualified 
medical trainees medication, unsafe barber shops and 
reuse of razors and shaving tools shows full efficiency in 
the transmission of these viruses. Our study contributes to 
identify and explore these sources and point the 
occurrence and spread of the disease in less educated 
areas of Pakistan. This study also provides a clue to high 
authorities to control the spread of these threats. 
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